Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
STOP IT!!!! LOL!
LOL!! eom
And I thought I was the only sarcastic A'hole here.. I was wrong...
LOL!!!
Historic trading volume is very low.. Perfect set up...
I'm at work and haven't had time to do any DD on it besides what was in MARK's post.. If the share structure is correct you can't go wrong.. IMO
Yep - Chart looking better. Slow & steady has allowed a lot of shares that were bought under .001 to be sold... Makes the next move up stronger without a massive sell off.. IMHO - We'll see..
I did the last 2 days.. Not willing to bite on it..
ECMT - .015 x .02 - One to watch
Mark Share Wednesday, January 05, 2011 9:51:08 AM
Re: levelnever post# 896 Post # of 899
1/4/11 - ECMT, Ecomat, Inc - Shell now Active on Nevada SOS.
Tiny 3.6M O/S & 75M Authorized Shares.
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=g2zAXJDPGrkSMLl3RzROQA%253d%253d&CorpName=ECOMAT%2c+INC.
Ecomat, Inc. filed a 15-12G in Feb 12, 1999.
Ivo Heiden Chairman, CEO/CFO
Maybe this is finally getting ready for a Reverse Merger!!!
VPRO - .023 x .024 -
Spectrum Pharmaceuticals In Deal With Viropro For Cancer DrugFont size: A | A | A7:44 AM ET 1/5/11 | Dow Jones
DOW JONES NEWSWIRES
Spectrum Pharmaceuticals Inc. (SPPI) signed a deal with biopharmaceutical company Viropro Inc. (VPRO) to develop a biosimilar version of Swiss pharmaceutical giant Roche Holding AG's (RHHBY, ROG.VX) cancer drug rituximab ahead of its U.S. patent expiration in 2015.
The agreement comes as a wave of patent expirations looms over large pharmaceutical companies. Rituximab, used in the treatment of many lymphomas, leukemias, transplant rejection and some autoimmune disorders, saw worldwide sales of about $5.6 billion in 2009.
Financial terms weren't disclosed, nor were other details of the collaboration.
Biosimilar drugs are officially approved versions of biopharmaceutical products made by a different company as patent and exclusivity expire on the product.
Biotech company Spectrum, which has a focus on cancer treatment, has been focused on making another push to improve the weak sales of its leading drug Zevalin. In its most recent quarterly results, Spectrum swung to a loss as it spent more to market Zevalin and another drug, Fusilev, which treats a vitamin deficiency in patients who have been treated with chemotherapy for colorectal cancer.
Meanwhile, Roche, the world's biggest maker of cancer drugs, is facing pressure as the U.S. Food and Drug Administration in December revoked approval of blockbuster drug Avastin for the treatment of breast cancer.
Spectrum shares were inactive premarket and closed Tuesday at $6.88. The stock is up 48% over 12 months.
-By Lauren Pollock, Dow Jones Newswires; 212-416-2356; lauren.pollock@dowjones.com;
We're always thinking a like
Right on.. Complete BS.. eom
I'm at work can't see it. Just posting the info. It isn't if you or I believe it. It's the masses...
HRNF - Nid Bid x .0001 - See how this POS plays out...
Heathrow Natural Food & Beverage, Inc. Board of Directors Approves Stock Re-Organization Plan For 2011
LAKE MARY, Fla., Jan 05, 2011 (BUSINESS WIRE) -- Heathrow Natural Food & Beverage, Inc. (OTCPK: HRNF) is pleased to announce that its board of directors has approved a stock re-organization plan for 2011, which includes no plan for a reverse split. Based on the stock re-purchase plan and projected 2011 revenues announced in last month's press releases, it will not be necessary to affect a reverse split for 2011 and beyond. The board has approved the re-purchase of 90% of the company's float over the first six months of 2011, which will be retired and placed back in the company's treasury pool. This will reduce the company's float to approximately 5 Million shares. In addition, the board has approved the reduction of the company's authorized common shares from 15 Billion to 500 Million. Upon the reduction of shares, rule 144 restricted shares will be issued to senior management and certain insiders.
"We are very pleased to be in a position to execute the stock re-organization and significantly increase the value of our PPS and market cap moving forward into 2011," said Michael Pagnano, CEO Heathrow Natural Food & Beverage, Inc. "All financing going forward, will be based on purchase orders and will have no impact on the share value or require any further dilution." We wish all of our customers and shareholders a Happy & Healthy New Year.
About Heathrow Natural Food & Beverage, Inc.: www.heathrownfb.com
HRNF - Nid Bid x .0001 - See how this POS plays out...
Heathrow Natural Food & Beverage, Inc. Board of Directors Approves Stock Re-Organization Plan For 2011
LAKE MARY, Fla., Jan 05, 2011 (BUSINESS WIRE) -- Heathrow Natural Food & Beverage, Inc. (OTCPK: HRNF) is pleased to announce that its board of directors has approved a stock re-organization plan for 2011, which includes no plan for a reverse split. Based on the stock re-purchase plan and projected 2011 revenues announced in last month's press releases, it will not be necessary to affect a reverse split for 2011 and beyond. The board has approved the re-purchase of 90% of the company's float over the first six months of 2011, which will be retired and placed back in the company's treasury pool. This will reduce the company's float to approximately 5 Million shares. In addition, the board has approved the reduction of the company's authorized common shares from 15 Billion to 500 Million. Upon the reduction of shares, rule 144 restricted shares will be issued to senior management and certain insiders.
"We are very pleased to be in a position to execute the stock re-organization and significantly increase the value of our PPS and market cap moving forward into 2011," said Michael Pagnano, CEO Heathrow Natural Food & Beverage, Inc. "All financing going forward, will be based on purchase orders and will have no impact on the share value or require any further dilution." We wish all of our customers and shareholders a Happy & Healthy New Year.
About Heathrow Natural Food & Beverage, Inc.: www.heathrownfb.com
lol - I will from now on... eom
Rereading your post again and again and again.. lol
Boardmarks rise yet only a handful of us post on here... A lot of eyes on this one.. More when the news hits
$1.50 per share...
RIGATONI
Tuesday, January 04, 2011 2:19:50 PM
Re: jmurfk post# 476 Post # of 491
Better make reservations for next week then
I couldn't agree more with ya!
Beautiful! We may see another chart breather like that at .015.. See you there...
Thanks Walker... Catch you tomorrow in penny land..
An understatement.. lol
ZLUS - .006's a come'n soon.. News possibly tomorrow.. What do you think? lol
Yep - Shares under attack!
ZLUS - .005 x .0055 now. Didn't see that coming.. Ok, maybe I did
Wait till its trading over $1.00. Then you'll need an armored truck..
lol - So true... eom
CNYC - ETMM Didn't have many shares for sale..
.40's up.. eom
ZLUS - I agree with you. I expect news to make this move to penny land.. JMHO
Yep - Was just thinking the same thing.. lol
People catching on.. eom
Rig, I'm going to re and reread that post for some time to come. Thank you very much for sharing that update with us...
$20.00 a share in copper
10k at .35 - Not a bad trade... Fun to be in this one and watch it continue to climb...
Exactly.. It'll keep trending up IMHO
8,000,000 shares just went thru.. eom
CNYC - Is the real deal...eom
You need to paint a better picture for me.. lol
Wowser.. What's that figure out per share of copper than?